BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28543513)

  • 1. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
    Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isomeric separation of permethylated glycans by extra-long reversed-phase liquid chromatography (RPLC)-MS/MS.
    Wang J; Dong X; Yu A; Huang Y; Peng W; Mechref Y
    Analyst; 2022 May; 147(10):2048-2059. PubMed ID: 35311852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isomeric Separation of Permethylated Glycans by Porous Graphitic Carbon (PGC)-LC-MS/MS at High Temperatures.
    Zhou S; Huang Y; Dong X; Peng W; Veillon L; Kitagawa DAS; Aquino AJA; Mechref Y
    Anal Chem; 2017 Jun; 89(12):6590-6597. PubMed ID: 28475308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
    Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
    J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
    Zhang S; Jiang K; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS analysis of permethylated free oligosaccharides and N-glycans derived from human, bovine, and goat milk samples.
    Dong X; Zhou S; Mechref Y
    Electrophoresis; 2016 Jun; 37(11):1532-48. PubMed ID: 26959529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS analysis of permethylated N-glycans facilitating isomeric characterization.
    Zhou S; Dong X; Veillon L; Huang Y; Mechref Y
    Anal Bioanal Chem; 2017 Jan; 409(2):453-466. PubMed ID: 27796453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Isomeric Glycan Structures by Permethylation and Liquid Chromatography-Mass Spectrometry (LC-MS).
    Cho BG; Banazadeh A; Peng W; Zhao J; Goli M; Gautam S; Hussein A; Mechref Y
    Methods Mol Biol; 2021; 2271():281-301. PubMed ID: 33908015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder.
    Dong X; Mondello S; Kobeissy F; Talih F; Ferri R; Mechref Y
    Electrophoresis; 2018 Dec; 39(24):3096-3103. PubMed ID: 30168606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Peng W; Goli M; Mirzaei P; Mechref Y
    J Proteome Res; 2019 Oct; 18(10):3731-3740. PubMed ID: 31430160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of isomeric glycan structures by LC-MS/MS.
    Veillon L; Huang Y; Peng W; Dong X; Cho BG; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2100-2114. PubMed ID: 28370073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
    Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving Isomeric Structures of Native Glycans by Nanoflow Porous Graphitized Carbon Chromatography-Mass Spectrometry.
    She YM; Tam RY; Li X; Rosu-Myles M; Sauvé S
    Anal Chem; 2020 Oct; 92(20):14038-14046. PubMed ID: 32960038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
    Zhang S; Shu H; Luo K; Kang X; Zhang Y; Lu H; Liu Y
    Mol Biosyst; 2011 May; 7(5):1621-8. PubMed ID: 21380457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of fucosylated N-glycan isomer separation with an ultrahigh column temperature in porous graphitic carbon liquid chromatography-mass spectrometry.
    Chen CH; Lin YP; Ren CT; Shivatare SS; Lin NH; Wu CY; Chen CH; Lin JL
    J Chromatogr A; 2020 Nov; 1632():461610. PubMed ID: 33080533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Potential Serum
    Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.